Search - tctmd.com

Displaying 1 - 20 of 59335

Sort: Relevancy | Date

News Conference News ACC 2026

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food Is Medicine’

L.A. McKeown

March 31, 2026

News Conference News ACC 2026

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

Todd Neale

March 30, 2026

News Conference News ACC 2026

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

Caitlin E. Cox

March 30, 2026

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

News Conference News ACC 2026

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

Yael L. Maxwell

March 30, 2026

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

News Industry News

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

March 30, 2026

Presentation ACC 2026

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

Presenter: Nicholas Marston

March 30, 2026

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

Presentation ACC 2026

Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease Primary Efficacy and Safety Results of the SirPAD Trial

Presenter: Stefano Barco

March 30, 2026

Presentation ACC 2026

THRIVE Food is Medicine Pilot Trial

Presenter: Oluwabunmi Ogungbe

March 30, 2026

News Conference News ACC 2026

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

Todd Neale

March 29, 2026

News Conference News ACC 2026

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

Michael O'Riordan

March 29, 2026

News Conference News ACC 2026

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

L.A. McKeown

March 29, 2026

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

News Conference News ACC 2026

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

Todd Neale

March 29, 2026

Presentation ACC 2026

Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina – (ORBITA-CTO) A randomized, placebo-controlled trial

Presenter: Sarosh Khan

March 29, 2026

Presentation ACC 2026

SPIRonolactone In the Treatment of Heart Failure

Presenter: Frank Edelmann

March 29, 2026

Presentation ACC 2026

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Presenter: Michiel Voskuil

March 29, 2026

Advertisement

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food Is Medicine’

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease Primary Efficacy and Safety Results of the SirPAD Trial

THRIVE Food is Medicine Pilot Trial

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina – (ORBITA-CTO) A randomized, placebo-controlled trial

SPIRonolactone In the Treatment of Heart Failure

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content